Vorinostat Recruiting Phase 1 Trials for Glioblastomas / Neoplasms, Brain / GBM Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03426891Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma